CRBP Corbus Pharmaceuticals Holdings Inc

Price (delayed)

$7.74

Market cap

$149.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.11

Enterprise value

$130.21M

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2

Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company with a diversified portfolio and is committed to helping people defeat serious illness by bringing innovative scientific approaches to well-understood ...

Highlights
Corbus Pharmaceuticals Holdings's net income has plunged by 76% YoY and by 21% from the previous quarter
CRBP's debt has soared by 74% year-on-year

Key stats

What are the main financial stats of CRBP

CRBP stock price

How has the Corbus Pharmaceuticals Holdings stock price performed over time
Intraday
-1.71%
1 week
6.61%
1 month
-25.43%
1 year
-32.93%
YTD
-4.91%
QTD
-17.48%

Financial performance

How have Corbus Pharmaceuticals Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$106.88M
Net income
-$101.9M
Gross margin
N/A
Net margin
N/A
Corbus Pharmaceuticals Holdings's net income has plunged by 76% YoY and by 21% from the previous quarter
The operating income has dropped by 59% year-on-year and by 19% since the previous quarter

Price vs fundamentals

How does CRBP's price correlate with its fundamentals

Growth

What is Corbus Pharmaceuticals Holdings's growth rate over time

Valuation

What is Corbus Pharmaceuticals Holdings stock price valuation
P/E
N/A
P/B
1.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Corbus Pharmaceuticals Holdings's EPS has decreased by 29% YoY and by 6% QoQ
CRBP's P/B is 78% below its 5-year quarterly average of 6.5
The company's equity fell by 19% QoQ and by 8% YoY

Efficiency

How efficient is Corbus Pharmaceuticals Holdings business performance
CRBP's return on invested capital has dropped by 123% year-on-year and by 23% since the previous quarter
The ROE has shrunk by 99% YoY and by 23% QoQ
The ROA has plunged by 87% YoY and by 20% from the previous quarter

Dividends

What is CRBP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRBP.

Financial health

How did Corbus Pharmaceuticals Holdings financials performed over time
CRBP's total liabilities has soared by 76% YoY and by 36% from the previous quarter
Corbus Pharmaceuticals Holdings's current ratio has decreased by 38% YoY and by 28% QoQ
CRBP's debt is 96% smaller than its equity
CRBP's debt to equity has soared by 100% year-on-year
CRBP's debt has soared by 74% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.